August Health Observance: Psoriasis Awareness Month

Psoriasis impacts millions, yet too many individuals face barriers to proper care and treatment.

Limited access to specialists, delayed diagnoses, and inconsistent care pathways can leave this chronic condition unmanaged—affecting overall health and quality of life.

Better care starts with visibility—and data makes it possible.

This Psoriasis Awareness Month, explore how Springbuk equips you to identify gaps in care, uncover key trends, and guide strategies that improve outcomes for those living with psoriasis.

Scroll down to put these tools and insights to work.
August Health Observance: Psoriasis Awareness Month

Springbuk Product Section

Top Drugs by Condition Report
Humira Savings

On-Demand Resources

Missed a recent deep dive webinar? Curious about additional Springbuk platform training? Good news! On-demand replays and resources are available in Springbuk University!

Click the topic tabs on the left to explore the Springbuk Product Section in more detail.

Is Psoriasis Driving Your Rx PMPM Increase?

Psoriasis is driving a significant share of rising Rx spend. According to Springbuk’s 2025 Employee Health Trends Report, it’s one of five conditions accounting for nearly two-thirds of the increase in Rx PMPM—fueled by a 6.4% jump in prevalence. Newer drugs like Rinvoq and Skyrizi may be displacing less expensive drugs.

Access your population’s ready-made Top Drugs by Condition in your Report Library. Use this report to understand what drugs your population may be taking for psoriasis and whether there are drug savings or condition management opportunities.

Understanding what drugs your population is taking for psoriasis enables you to identify lower-cost drug alternatives and other treatment opportunities.

Get your Top Drugs By Condition Report

Learn More

Click the topic tabs on the left to explore the Springbuk Product Section in more detail.

Save by Switching to Biosimilars

Humira (adalimumab) is a biologic drug used in treatment of psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis and Crohn's disease.

Eight biosimilars for Humira are currently available in the United States, with wholesale acquisition costs ranging from 5% - 86% less than Humira.

See if there are opportunities for Humira savings by going to the Insights tab in the Springbuk platform.

Go to Insights

The Insight Cards displayed are based on your organization’s actual data. Card visibility varies by client, depending on your population’s condition profile and care utilization patterns.

Learn More

On-Demand Resources

Missed a recent deep dive webinar? Curious about additional Springbuk platform training? Good news! On-demand replays and resources are available in Springbuk University!

Springbuk Activate Partner: RxBenefits

For employees managing chronic conditions like psoriasis, affordable access to the right medications is critical. RxBenefits is a pharmacy benefits optimizer (PBO) that helps self-funded employers deliver high-quality, cost-effective prescription benefit programs—no matter their size.

With market-leading purchasing power, independent clinical oversight, and a service model built for exceptional care, RxBenefits ensures employees get the medications they need while employers control rising pharmacy costs.

Curious how a partnership with RxBenefits could support your strategy? Click here to request more information.

Supporting over 3 million members, RxBenefits makes providing a valuable, affordable pharmacy benefit plan achievable for every plan sponsor.

See It In Action

Springbuk Activate Partner: RxProtect

Managing chronic conditions like psoriasis often comes with costly medications—but RxProtect is changing that. This groundbreaking program helps self-insured employers save 30-40% on prescription costs while improving medication adherence.

By removing cost barriers, RxProtect supports consistent treatment for conditions like psoriasis, potentially lowering future premiums and reducing long-term health risks. Best of all, it integrates seamlessly with existing benefit plans, no financial risk required.

Curious how a partnership with RxProtext could support your strategy? Click here to request more information.

Healthier, happier employees start with access to the care they need—RxProtect makes that possible.

See It In Action

Please note: The information contained in the Springbuk application is for educational and informational purposes only. We encourage you to use your judgment and conduct due diligence before taking any action or implementing any plans or policies suggested or recommended here. It may also be appropriate to consult your third party administrator or stop loss carrier before making partnership decisions. We believe in empowering you to make informed decisions, but ultimately, your program results will depend on your efforts, your unique situation, and various other factors beyond our control and knowledge.

From Insight to Impact: Health Intelligence in Action

You’ve explored the tools—now make them work for you. Dive into the following curated resources to experience the power of actionable insights and amplify the impact they can deliver for your population.

Insight: Psoriatic disease triggers a “domino effect” of comorbid conditions—including heart disease, diabetes, obesity, and depression—that significantly raise total healthcare costs.    

Employers who proactively educate and screen for these related conditions during Psoriasis Awareness Month can reduce long-term claims while supporting whole-person health.

Actionable Opportunity: Kick off Psoriasis Awareness Month by sharing the National Psoriasis Foundation’s Employer Toolkit.

It includes ready-to-use posters, digital content, and fact sheets to help promote early detection, treatment engagement, and comorbidity screening.

Click, "Learn More" to access the Psoriasis Action Month Employer Toolkit from the National Psoriasis Foundation

Learn More

Insight: Many psoriasis patients go undiagnosed or misclassified, delaying effective treatment and increasing disease burden.

Evidence: A UK study utilizing 17,000 patient records found that individuals with psoriasis were ~8× more likely to be misdiagnosed with conditions like eczema or tinea before receiving a proper psoriasis diagnosis.

Actionable Opportunity: Track claims and pharmacy data to flag undiagnosed or under-treated populations such as:
  • Repeated use of topical corticosteroids without dermatologist visits
  • Claims for joint pain + eczema diagnosis without a PsA consult
  • Higher-than-average ER or urgent care visits related to skin infections or joint pain

Click, "Learn More" to access the full study from the University of Manchester

Learn More

Insight: Approximately 30% of US psoriasis patients develop psoriatic arthritis (PsA)—a chronic, inflammatory joint disease that is often underdiagnosed, leading to irreversible joint damage and significantly higher healthcare costs.

Comprehensive care coordination across dermatology, rheumatology, and primary care can reduce the risk of late-stage complications, prevent avoidable surgeries or ER visits, and lower overall healthcare claims.

Actionable Opportunity: Embed care coordination services in health plans or navigation platforms.
  • Activate nurse case managers trained in autoimmune and inflammatory conditions.
  • Ensure referrals between dermatologists and rheumatologists are streamlined and covered within the network.
  • Provide outreach to members with psoriasis or inflammatory diagnoses to help them navigate benefit coverage, specialty pharmacy, and step therapy appeals.

Click, "Learn More" to access Psoriatic Arthritis Statistics from the National Psoriasis Foundation

Learn More

Insight: Visible psoriasis lesions frequently trigger stigma, shame, and social isolation, deeply affecting self-esteem and mental health—even when clinical disease severity is low.

Combat stigma and promote inclusion to improve well-being, treatment engagement, attendance, and long-term health for employees with psoriasis.

Actionable Opportunity: Launch Psoriasis Awareness Month campaigns focused on destigmatization through personal stories, myth-busting resources, and guidance on supportive language and behavior.

Include group support or peer coaching sessions to build belonging and shared experiences.

Click, "Learn More" to access the Patient Helpline’s Toolkit for Supporting Chronically Ill Employees

Learn More

Insight: Increased physical activity has been shown to significantly improve both skin disease severity and psychological wellbeing in people with psoriasis.

Employers that promote and incentivize movement—especially among members with chronic inflammatory conditions like psoriasis—can drive better physical and mental health outcomes while reducing long-term medical claims.

Actionable Opportunity: 
  • Include psoriasis-specific fitness content in wellbeing apps and portals.
  • Integrate movement challenges during Psoriasis Awareness Month, offering incentives for participation.
  • Ensure psoriasis is considered in the design of EAP, physical wellness, and chronic care programs—particularly for members with limited mobility or comorbid conditions.
  • Share evidence with members via your wellness platform using resources from the National Psoriasis Foundation

Click, "Learn More" to access an activity study published in Skin Health and Disease

Learn More

Insight: People with psoriasis who are actively engaged in managing their condition—including tracking symptoms, following treatment plans, and seeking mental health support—report better physical and emotional outcomes.

Actionable Opportunity: Empowering patients with tools, education, and encouragement to take an active role in their psoriasis management can reduce flare-ups, improve mental health, and reduce costly escalations in care.  

Encourage members to download the free Psoriasis Progress tracker sheet to log daily data such as mood, treatment use, sleep, and flare triggers.

Click, "Learn More" to access a Psoriasis Progress Tracker Sheet

Learn More